Latest Update on Bayer’s Yaz Lawsuit Settlement

The Yaz Resource Center is the Web’s largest source for information on Yaz research, side effects and legal news. Visit http://www.YazLawsuit.com

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
yaz settlement
Quote startLawyers are currently helping those affected file claims and settle cases.Quote end

Dallas, TX (PRWEB) June 12, 2012

The Yaz Resource Center, a patient advocacy group, is alerting those women who experienced side effects after taking the birth control drugs Yaz and Yasmin that the maker of the drug is settling injury claims. Lawyers are currently helping those affected protect their legal rights.

Recently, Bayer Pharmaceuticals gave an indication of which types of cases it would agree to settle and what the average amount would be.

According to a federal Multi-District Litigation court in Illinois set up to handle the cases, more than 10,000 people have filed a Yaz lawsuit. The formal case is known as Yasmin and Yaz (Drospirenone) Marketing, Sales Practices and Products Liability Litigation (MDL No. 2100).

Many of the lawsuits have been filed by women who have suffered stroke, Deep Vein Thrombosis or Pulmonary Embolism after taking Yaz. Recent studies in Europe and the United States have linked drugs like Yaz and Yasmin with the chemical drospirenone to blood clots, which can cause these conditions.

On October 25, 2011, The British Medical Journal published a study from The University of Copenhagen in Denmark which linked the chemicals in Yaz to blood clots.

On October 27, 2011, the FDA also released a study entitled "Combined Hormonal Contraceptives (CHCs) and the Risk of Cardiovascular Disease Endpoints" which included the birth control pills Yaz and Yasmin. Following over 825,000 women taking oral contraceptives, the study found that drugs like Yaz could cause up to a 74% increased risk of developing blood clots, DVT and pulmonary embolism.

Bloomberg News originally reported on April 13, 2012 that Bayer would settle 500 of the lawsuits at approximately $220,000 per case. The company has now reported in its Stockholders’ Newsletter for the first quarter that it has paid $142 million in settlements, at an average of about $218,000 a case.

The report added, “Bayer is only settling claims in the U.S. for venous clot injuries after a case specific analysis of medical records.” These would include claims for stroke, pulmonary embolism and DVT.

The Yaz Resource Center cautions that only certain lawyers may be able to obtain a Yaz lawsuit settlement. Victims will also have to submit the proper medical records and paperwork. The Resource Center only recommends lawyers and law firms who have already settled Yaz lawsuits.

Anyone affected by stroke, DVT or pulmonary embolism after taking Yaz should learn their legal rights today.

For more information on research, side effects of yaz and litigation news related to the drug Yaz, or to speak with a lawyer, visit http://www.YazLawsuit.com.


Contact